Evio has advanced analytics and contracting capabilities at scale, and a suite of digital tools, to power our solutions for high-cost medications. Our solutions act as a self-reinforcing “flywheel” where each element strengthens and feeds into the next.
Real-World Evidence Analytics at Scale
Innovative Medication Contracts at Scale
Medication Insights Delivery
Medication Outcomes Verification
More than 20 million lives of medical and pharmacy claims data. Five years of longitudinal data.
Nationally recognized team of health economics outcomes research specialists and clinical pharmacists with cross-disciplinary skills and 30+ years of experience.
The Aetion Evidence Platform enables rapid, rigorous, and replicable RWE studies in a secure cloud environment.
RWE studies produce medication-specific analyses that impact health plan strategies and workflows, delivered in the interactive Evio Insights portal.
Helps health plans make strategic formulary and benefit design decisions, decrease medication waste and spend, lower costs through better patient outcomes, and understand drug effectiveness.
Informs creative value-based contracting opportunities by revealing comparative medication effectiveness. Study findings highlight positive clinical outcomes to prove the value of certain medications.
Evio provides plan-specific solutions to maximize impact from RWE research findings — playbooks containing the full studies, patient specific intervention recommendations, interactive cloud-based dashboards, and personalized in-workflow outreach to providers.
Innovative direct purchase business models with pharmaceutical manufacturers leveraging Evio-generated Real-World Evidence to increase transparency, streamline delivery of care to patients, and lower total cost of care.
Design and administration of value-based agreements to align incentives between Evio’s health plan customers and pharmaceutical manufacturers, promote effective medications, and mitigate risk of failed treatments.
Evio’s transparent arrangements reduce cost and complexity in the system, offering health plans and their members effective medications without barriers and added cost.
Customized partnerships for innovative manufacturers to build a cost-effective market access strategy.
Proprietary Evio Engage platform to collect data from claims and providers to utilize for longitudinal patient tracking, analysis, and validation.
Analytical validation of outcomes, collecting new data elements, and patient-reported outcomes to inform real-world evidence analytics and medication contracting.
Evio enables the Gene + Outcomes program of Synergie Medication Collective across more than 60M lives. Synergie’s value-based cell and gene therapy contracts are administered using Evio Engage.
Analytics and reporting on rebates, warranties, and other outome-related payment calculations.
Proprietary Evio Engage technology gathers and analyzes drug effectiveness data, enabling value-based contracts with pharma.
A single technology platform for data collection to serve patients across several health plans and employers.
Proprietary Evio Engage technology gathers and analyzes drug effectiveness data from patients using the medication, which enables our value-based contracts.
The technology platform that enables simple data collection from physician offices to monitor patient outcomes on medications over time.